How does intermittent fasting stack up as a diet option for teens with obesity?

Publicly released:
Australia; NSW; VIC; QLD
CC:0
CC:0

Intermittent fasting may be as effective as a continuous low-calorie diet for teenagers with obesity going through an intensive weight management program, according to Australian research. The researchers examined the effectiveness of two different types of diets for 141 teens with obesity and an obesity-related health complications participating in a year-long randomised weight management trial comparing intermittent energy restriction (where eating is only allowed within a restricted time window) and continuous energy restriction (where a restricted amount of calories are allowed each day). After a year, the researchers say nearly 70% of the teens completed the program, including 43 in the intermittent group and 54 in the continuous group. Health improvements were similar for both groups, the researchers say, which shows intermittent fasting can be considered as another option for teenagers wanting an intensive obesity intervention. In a second paper on the same study, researchers monitored the teens' depression, eating disorder and binge eating symptoms before, during and after the study. They say symptoms were reduced for most, but some of the teens required additional support with their mental health.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Paper 1. The URL will go live after the embargo ends
Research JAMA, Web page Paper 2. The URL will go live after the embargo ends
Journal/
conference:
JAMA Pediatrics
Research:Paper
Organisation/s: The University of Sydney, Monash University, The University of Newcastle, The University of Melbourne, La Trobe University, Hunter Medical Research Institute, University of Queensland
Funder: This study was funded by grant 1128317 from the NHMRC. Dr Lister is supported by grant 114574 from the NHMRC Peter Doherty Early Career Fellowship program. Dr Baur is supported by NHMRC Leadership (L3) Investigator Grant 2009035. Dr Collins is supported by NHMRC Leadership (L3) Investigator Grant 2009340. Dr Gow is supported by NHMRC Peter Doherty Early Career Fellowship 1158876. Dr Varady is supported by grants R01DK128180, R01CA257807, and R01 DK119783 from the National Institutes of Health. Dr Jebeile is supported by NHMRC Emerging Leadership Investigator Grant 2017139.
Media Contact/s
Contact details are only visible to registered journalists.